抑郁症慢性化程度增加与美国HIV感染成人预约就诊、治疗失败及死亡率的关联
本研究为观察性临床队列,纳入5927例在美国6家学术医疗中心接受HIV初级保健且至少完成2次抑郁严重度评估的成人。PDD每增加25%,错过预约风险增加8%、可检测病毒载量风险增加5%、死亡风险增加19%,呈剂量反应关系。
要点
- 抑郁慢性化程度越高,HIV照护连续体多个环节失败风险越高。
- PDD每增加25%,错过预约风险比1.08、可检测病毒载量风险比1.05、死亡风险比1.19。
- PDD 100%者较PDD 0%者死亡风险翻倍(HR 2.02)。
核心结论
- 抑郁慢性化程度增加与HIV照护连续体多环节失败风险升高相关,即使抑郁时间比例 modest 增加也有临床意义。
研究设计与样本
- 观察性临床队列,纳入5927例在6家美国学术医疗中心接受HIV初级保健且至少2次抑郁严重度评估的成人,随访2005年9月22日至2015年8月6日。
主要发现
- PDD每增加25%,错过预约风险比1.08(95%CI 1.05-1.11),可检测病毒载量风险比1.05(95%CI 1.01-1.09),死亡风险比1.19(95%CI 1.05-1.36)。
- PDD 100%较PDD 0%者,错过预约风险比1.37(95%CI 1.22-1.53),可检测病毒载量风险比1.23(95%CI 1.06-1.43),死亡风险比2.02(95%CI 1.20-3.42)。
关键数值与推荐
- 可检测HIV RNA病毒载量定义为≥75 copies/mL。
- PDD由连续抑郁严重度测量转换为时间更新指标,基于无抑郁天数既定方法计算。
临床怎么用
- 对HIV成人应常规筛查抑郁并及时治疗,以缩短抑郁病程、预防复发并改善HIV照护结局。
- 临床可关注抑郁慢性化程度(如PDD)以识别错过预约、治疗失败和死亡高风险患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Depression commonly affects adults with HIV and complicates the management of HIV. Depression among individuals with HIV tends to be chronic and cyclical, but the association of this chronicity with HIV outcomes (and the related potential for screening and intervention to shorten depressive episodes) has received little attention. OBJECTIVE: To examine the association between increased chronicity of depression and multiple HIV care continuum indicators (HIV appointment attendance, treatment failure, and mortality). DESIGN, SETTING, AND PARTICIPANTS: The study comprised an observational clinical cohort of 5927 patients with 2 or more assessments of depressive severity who were receiving HIV primary care at 6 geographically dispersed US academic medical centers from September 22, 2005, to August 6, 2015. MAIN OUTCOMES AND MEASURES: Missing a scheduled HIV primary care visit, detectable HIV RNA viral load (≥75 copies/mL), and all-cause mortality. Consecutive depressive severity measures were converted into a time-updated measure: percentage of days with depression (PDD), following established methods for determining depression-free days. RESULTS: During 10 767 person-years of follow-up, the 5927 participants (5000 men, 926 women, and 1 intersex individual; median age, 44 years [range, 35-50 years]) had a median PDD of 14% (interquartile range, 0%-48%). During follow-up, 10 361 of 55 040 scheduled visits (18.8%) were missed, 6191 of 28 455 viral loads (21.8%) were detectable, and the mortality rate was 1.5 deaths per 100 person-years. Percentage of days with depression showed a dose-response relationship with each outcome. Each 25% increase in PDD led to an 8% increase in the risk of missing a scheduled appointment (risk ratio, 1.08; 95% CI, 1.05-1.11), a 5% increase in the risk of a detectable viral load (risk ratio, 1.05; 95% CI, 1.01-1.09), and a 19% increase in the mortality hazard (hazard ratio, 1.19; 95% CI, 1.05-1.36). These estimates imply that, compared with patients who spent no follow-up time with depression (PDD, 0%), those who spent the entire follow-up time with depression (PDD, 100%) faced a 37% increased risk of missing appointments (risk ratio, 1.37; 95% CI, 1.22-1.53), a 23% increased risk of a detectable viral load (risk ratio, 1.23; 95% CI, 1.06-1.43), and a doubled mortality rate (hazard ratio, 2.02; 95% CI, 1.20-3.42). CONCLUSIONS AND RELEVANCE: Greater chronicity of depression increased the likelihood of failure at multiple points along the HIV care continuum. Even modest increases in the proportion of time spent with depression led to clinically meaningful increases in negative outcomes. Clinic-level trials of protocols to promptly identify and appropriately treat depression among adults living with HIV should be conducted to understand the effect of such protocols on shortening the course and preventing the recurrence of depressive illness and improving clinical outcomes.
引用
- Pence BW, Mills JC, Bengtson AM, et al. Association of Increased Chronicity of Depression With HIV Appointment Attendance, Treatment Failure, and Mortality Among HIV-Infected Adults in the United States. JAMA Psychiatry. 2018. PMID: 29466531. doi:10.1001/jamapsychiatry.2017.4726
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。